SciELO - Scientific Electronic Library Online

 
vol.70 número2Calidad de vida relacionada con la salud en pacientes con angioedema hereditario de Argentina. Estudio multicéntricoEnfermedad de Kawasaki y síndrome inflamatorio multisistémico en niños. Diferencias y similitudes en un centro pediátrico de México índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista alergia México

versão On-line ISSN 2448-9190

Resumo

HERNANDEZ-MORALES, María del Rocío et al. Adverse drug events in hospitalized patients: prevalence, causes and risk factors. Rev. alerg. Méx. [online]. 2023, vol.70, n.2, pp.72-79.  Epub 28-Ago-2023. ISSN 2448-9190.  https://doi.org/10.29262/ram.v70i2.1117.

Objective:

To determine prevalence, causes and risk factors of ADE in hospitalized patients of a General Hospital.

Methods:

Observational and analytical case-control study, carried out in patients hospitalized for adverse drug events, treated at the Hospital General Dr. Eduardo Vázquez N, in Puebla, Mexico, between, June 2019 to June 2021. For the statistical analysis, percentages, frequencies, means, odds ratio, x², and multiple binary logistic regression were used. Data were analyzed using the Statistical Package for the Social Sciences 23 program.

Results:

A total of 132 patients (66 cases and 66 controls) were registered. Of the group of cases, 26 patients treated for medication error and 40 with adverse drug reaction were reported. The prevalence of adverse drug events was 3.6%. The drugs and factors associated with the most reported adverse events were: antibiotics, anti-inflammatories; average age of 35 years (SD: 17.41); gender: 39.3% men, 60.7% women; services reported with the greatest attention: Emergencies and Surgery; frequent route of administration: intravenous (32.3%); main symptoms: skin; symptoms associated with adverse drug reactions: type A pruritus [OR: 8.5, p = 0.001(CI95%: 0.035-0.393)], type B pruritus [OR: 11, p = 0.001 (CI95%: 0.021-0.368)]; urticaria [OR: 19, p = 0.005(CI95%: 0.007-0.412)]. Risk factors associated with adverse events were: female gender [OR: 2.6, p = 0.05 (CI95%: 1.33-5.43)], history of allergy [OR: 3.4, p = 0.033 (CI95%: 1.04-8.40)] and prolonged hospital stay [OR: 5.4, p = 0.023 (CI95%: 3.82-6.74)].

Conclusions:

The majority of ADEs were EM or ADR type A, both preventable reactions, so patient safety should be a priority when prescribing.

Palavras-chave : Adverse drug reaction; Medication error; drugs hypersensitivity.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )